Clinical Trials Browser

Observational × HER2-positive Breast Cancer × 90 days × Clear all

NCT06518382 2026-04-15

Tumor-microenvironment Spatial Interaction to Identify Markers of Resistance to Therapy in HER2+ Breast Cancer Patients

HER2-positive Breast Cancer

NCT07470203 2026-03-13

Pyrotinib Combined With Trastuzumab and Pertuzumab for Maintenance Therapy in HER2-Positive Advanced Breast Cancer

Not yet recruiting

HER2-positive Breast Cancer